Treating Cancer in the UK: Must do better

20th September 2022, 12:00 am




Professor Richard Sullivan

Richard is a very valued member of TLC and also serves on TLC Health & Social Care Forum.

You may recall that Richard and fellow TLC member Mike Meyer gave a memorable presentation in June last year entitled ‘CANCER CARE AT THE CROSSROADS: Lessons from the pandemic and where to go now’. Well, where are we 15 months on and what is needed to improve matters. Professor Sullivan will give us his up-to-date perspective and thoughts on the issues.


Richard Sullivan is Professor of Cancer and Global Health at King’s College London, Director of the King’s Institute of Cancer Policy and co-Director of the Conflict and Health Research Group. Richard’s global cancer research covers cancer systems strengthening, financing, political economy, global radiotherapy, social welfare and cancer care in conflict. He also leads major programs on conflict and health across the Middle East, global health security & intelligence and a wide range of clinical areas, particularly blast and ballistic injuries. Professor Sullivan qualified in medicine and trained in surgery (urology) gaining his PhD in Biochemistry from University College London. Richard was Clinical Director of Cancer Research UK between 1999 and 2008. He is Editor-in-Chief of Journal of Cancer Policy and national cancer advisor to a number of governments. He has worked for many years as well on biosecurity and biological counterproliferation issues in both civilian and security sectors, including Ebola outbreaks in West Africa & DR Congo and most recently COVID-19 pandemic.  Richard is an NCD advisor to the WHO, a member of the National Cancer Grid of India and civil-military advisor to Save the Children, amongst many other positions.